HomeCompareBCVVF vs ABBV

BCVVF vs ABBV: Dividend Comparison 2026

BCVVF yields 4.43% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCVVF wins by $3136.23M in total portfolio value
10 years
BCVVF
BCVVF
● Live price
4.43%
Share price
$9.36
Annual div
$0.41
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3136.33M
Annual income
$3,005,974,356.51
Full BCVVF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — BCVVF vs ABBV

📍 BCVVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCVVFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCVVF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCVVF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCVVF
Annual income on $10K today (after 15% tax)
$376.53/yr
After 10yr DRIP, annual income (after tax)
$2,555,078,203.03/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, BCVVF beats the other by $2,555,057,147.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCVVF + ABBV for your $10,000?

BCVVF: 50%ABBV: 50%
100% ABBV50/50100% BCVVF
Portfolio after 10yr
$1568.22M
Annual income
$1,502,999,564.13/yr
Blended yield
95.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

BCVVF
No analyst data
Altman Z
1.2
Piotroski
7/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCVVF buys
0
ABBV buys
0
No recent congressional trades found for BCVVF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCVVFABBV
Forward yield4.43%3.06%
Annual dividend / share$0.41$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.6%
Portfolio after 10y$3136.33M$102.3K
Annual income after 10y$3,005,974,356.51$24,771.77
Total dividends collected$3127.10M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BCVVF vs ABBV ($10,000, DRIP)

YearBCVVF PortfolioBCVVF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$11,586$885.96$11,550$430.00+$36.00BCVVF
2$14,316$1,918.64$13,472$627.96+$844.00BCVVF
3$19,749$4,431.16$15,906$926.08+$3.8KBCVVF
4$32,557$11,426.04$19,071$1,382.55+$13.5KBCVVF
5$70,045$35,208.58$23,302$2,095.81+$46.7KBCVVF
6$216,535$141,586.76$29,150$3,237.93+$187.4KBCVVF
7$1,049,818$818,125.55$37,536$5,121.41+$1.01MBCVVF
8$8,537,301$7,413,995.81$50,079$8,338.38+$8.49MBCVVF
9$121,830,055$112,695,143.25$69,753$14,065.80+$121.76MBCVVF
10$3,136,332,516$3,005,974,356.51$102,337$24,771.77+$3136.23MBCVVF

BCVVF vs ABBV: Complete Analysis 2026

BCVVFStock

BOC Aviation Limited, together with its subsidiaries, operates as an aircraft operating leasing company worldwide. It offers a range of services to airlines and aircraft owners, including direct operating leases, sale and leaseback facilities, and third-party asset management. The company also provides aircraft remarketing and technical management services to airlines, banks, and other investors; arranges debt financing and other financial services for airlines and aircraft investors; and sells aircrafts. As of December 31, 2021, it had a fleet of 521 owned, managed, and on order aircraft. The company was incorporated in 1993 and is headquartered in Singapore. BOC Aviation Limited is a subsidiary of Sky Splendor Limited.

Full BCVVF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this BCVVF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCVVF vs SCHDBCVVF vs JEPIBCVVF vs OBCVVF vs KOBCVVF vs MAINBCVVF vs JNJBCVVF vs MRKBCVVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.